EA200200518A1 - Способ и композиция для лечения заболеваний легких - Google Patents

Способ и композиция для лечения заболеваний легких

Info

Publication number
EA200200518A1
EA200200518A1 EA200200518A EA200200518A EA200200518A1 EA 200200518 A1 EA200200518 A1 EA 200200518A1 EA 200200518 A EA200200518 A EA 200200518A EA 200200518 A EA200200518 A EA 200200518A EA 200200518 A1 EA200200518 A1 EA 200200518A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pulmonary diseases
treatment
composition
phosphodiesterase
asthma
Prior art date
Application number
EA200200518A
Other languages
English (en)
Russian (ru)
Inventor
Петер Н. Гудфеллоу
Ричард Нимэн
Теодор Дж. Торфи
Original Assignee
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Корпорейшн
Publication of EA200200518A1 publication Critical patent/EA200200518A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EA200200518A 1999-11-02 2000-11-01 Способ и композиция для лечения заболеваний легких EA200200518A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
EA200200518A1 true EA200200518A1 (ru) 2002-10-31

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200518A EA200200518A1 (ru) 1999-11-02 2000-11-01 Способ и композиция для лечения заболеваний легких

Country Status (29)

Country Link
EP (1) EP1225866A4 (cs)
JP (1) JP2003513028A (cs)
KR (1) KR20020057988A (cs)
CN (1) CN1387404A (cs)
AP (1) AP2002002496A0 (cs)
AR (1) AR029189A1 (cs)
AU (1) AU1357501A (cs)
BG (1) BG106748A (cs)
BR (1) BR0015270A (cs)
CA (1) CA2388333A1 (cs)
CO (1) CO5261512A1 (cs)
CZ (1) CZ20021512A3 (cs)
DZ (1) DZ3225A1 (cs)
EA (1) EA200200518A1 (cs)
EC (1) ECSP003747A (cs)
HK (1) HK1049107A1 (cs)
HU (1) HUP0203152A3 (cs)
IL (1) IL149367A0 (cs)
MA (1) MA26841A1 (cs)
MX (1) MXPA02004350A (cs)
NO (1) NO20022057L (cs)
OA (1) OA12076A (cs)
PE (1) PE20011005A1 (cs)
PL (1) PL355261A1 (cs)
SK (1) SK7592002A3 (cs)
TR (1) TR200201211T2 (cs)
TW (1) TWI242431B (cs)
WO (1) WO2001032127A2 (cs)
ZA (1) ZA200203435B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160271A0 (en) * 2001-09-19 2004-07-25 Altana Pharma Ag Pharmaceutical compositions containing pde4-inhibitors and nsaid
CZ2004516A3 (cs) * 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CN1767828A (zh) * 2003-03-31 2006-05-03 协和发酵工业株式会社 医药组合物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1810692A1 (en) * 2004-10-13 2007-07-25 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000139A1 (en) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
MXPA02004350A (es) 2002-11-07
AP2002002496A0 (en) 2002-06-30
JP2003513028A (ja) 2003-04-08
NO20022057D0 (no) 2002-04-30
WO2001032127A2 (en) 2001-05-10
HK1049107A1 (zh) 2003-05-02
ECSP003747A (es) 2002-05-23
CN1387404A (zh) 2002-12-25
CA2388333A1 (en) 2001-05-10
HUP0203152A3 (en) 2004-06-28
OA12076A (en) 2006-05-04
IL149367A0 (en) 2002-11-10
BR0015270A (pt) 2002-06-18
AU1357501A (en) 2001-05-14
SK7592002A3 (en) 2002-11-06
HUP0203152A2 (hu) 2003-01-28
EP1225866A4 (en) 2004-04-21
TR200201211T2 (tr) 2002-08-21
DZ3225A1 (fr) 2001-05-10
NO20022057L (no) 2002-06-27
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
ZA200203435B (en) 2003-06-25
MA26841A1 (fr) 2004-12-20
EP1225866A2 (en) 2002-07-31
AR029189A1 (es) 2003-06-18
PE20011005A1 (es) 2001-09-28
PL355261A1 (en) 2004-04-05
CO5261512A1 (es) 2003-03-31
TWI242431B (en) 2005-11-01
CZ20021512A3 (cs) 2003-04-16
WO2001032127A3 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
WO2003000241A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika; corticosteroiden und betamimetika zur behandlung von entzündlichen und/oder obstruktiven atemwegserkrankungen
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
ATE178044T1 (de) Inhibitoren des arginin-ketoamid-enzyms
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
WO2002004449A3 (en) Methods for treatment of conditions affected by activity of multidrug transporters
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA200101214A1 (ru) Замещенные полициклические арил- и гетероарилпиримидиноны, используемые в качестве антикоагулянтов
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE457177T1 (de) Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
EA200300152A1 (ru) Фармацевтический препарат сальметерола и пропионата флутиказона
BG105953A (bg) Метод за лечение на хронична обструктивна белодробна болест
SE9900834D0 (sv) Novel combination
EA200001140A1 (ru) СОЕДИНЕНИЯ-ИНГИБИТОРЫ sPLA2 ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ
WO2004045530A3 (en) Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors
DE60219680D1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit